FDA Issues Warning to Active Pharmaceutical Ingredient Supplier Over Facility Deficiencies
Source Summary
The FDA has warned an active pharmaceutical ingredient supplier about multiple facility compliance issues, including residue on walls, a corroded product line, and employees wearing open-toed sandals. The warning included photographic documentation of the deficiencies.
Why it matters
FDA warnings to pharmaceutical suppliers signal manufacturing deficiencies that could compromise the safety and purity of active ingredients used in medications.
